Resources
The Long View
Increased regulation of financial markets
If laws are not strict enough, the credit bubble shows that markets cannot be trusted to regulate themselves, writes John Authers
Principal content
Overview: Stock market euphoria at US rescue plans
The most turbulent week in the financial markets in two decades came to a record-breaking end as some European stock markets saw their biggest ever one-day gains while Wall Street powered higher for a second consecutive day
Wall St enjoys record two-day rally
Financial sector soars 11 per cent
SEC unveils temporary shorting ban
Covers 799 companies including AIG
US money market funds aided
Offers insurance as crisis spreads
Gold, oil react sharply amid selling pressure
Hedge funds forced to reduce positions
Dollar muted in spite of turmoil
Rising risk appetite hits yen
UK banks jump on short-selling ban
FTSE 100 stages biggest one-day rally
European bourses surge amid relief rally
Irish banks gain on short-selling curbs
Russian market soars after bail-out
Kremlin tensions pressure finance minister
Related content and features
On Wall Street
It is not just about money, this storm will shatter lives
The crisis stemming from more than a year of credit market turmoil is the worst to hit financial markets since 1929, writes Anuj Gangahar
On London
Looking back to the future may be our only hope
It may struggle to make progress, but the FTSE 100 seems unlikely to plumb the depths reached earlier in the week, writes Neil Hume
Analysis
Week in markets: Drama that triggered the unthinkable
Extraordinary week sees US government become lender of last resort, writes Michael Mackenzie
Video
Wind of Change - Wall Street’s Wild Week
John Authers looks at possibly the most chaotic week on Wall Street in history
UK Daily View
Martin Wolf on the purported US government plan to take on banks’ toxic assets
Daily View: Wall Street rescue
Francesco Guerrera says the Treasury’s plan to take on Wall Street’s troubled assets is a trade-off
Mergermarket
- M&A, partnerships remain mainstay for smaller devices and pharma companies
- Avastin may increase risk of neural bleeding and stroke in patients with glioblastoma multiforme, physicians say
- Lehman counterparties scramble to stake claims but CSO holders could turn a profit, sources say
- Invensys looking to sell Controls business; finding buyer tricky
CLASSIFIED